Prescription Drug User Fee Act V Benefit-Risk Plan
Document ID: FDA-2013-N-0196-0001
Comments
Total: 14
-
National Organization for Rare Disorders- Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0002 Agency : FDA -
May 07,2013 11:59 PM ET
-
Accelerate Cure/Treatments for Alzheimer's Disease - Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0003 Agency : FDA -
May 07,2013 11:59 PM ET
-
Centre for Innovation in Regulatory Science - Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0004 Agency : FDA -
May 07,2013 11:59 PM ET
-
National Brain Tumor Society - Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0005 Agency : FDA -
May 07,2013 11:59 PM ET
-
National Organization for Rare Disorders (NORD) - Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0006 Agency : FDA -
May 07,2013 11:59 PM ET
-
Children's Cause for Cancer Advocacy - Comment
Posted : 05/13/2013 ID :FDA-2013-N-0196-0007 Agency : FDA -
May 07,2013 11:59 PM ET
-
National Psoriasis Foundation - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0008 Agency : FDA -
May 07,2013 11:59 PM ET
-
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0009 Agency : FDA -
May 07,2013 11:59 PM ET
-
Biotechnology Industry Organization (BIO) - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0010 Agency : FDA -
May 07,2013 11:59 PM ET
-
Roche Genentech - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0011 Agency : FDA -
May 07,2013 11:59 PM ET
-
National Health Council - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0012 Agency : FDA -
May 07,2013 11:59 PM ET
-
The Leukemia & Lymphoma Society - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0013 Agency : FDA -
May 07,2013 11:59 PM ET
-
Cystic Fibrosis Foundation - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0014 Agency : FDA -
May 07,2013 11:59 PM ET
-
Cancer Leadership Council - Comment
Posted : 05/21/2013 ID :FDA-2013-N-0196-0015 Agency : FDA -
May 07,2013 11:59 PM ET